相关实验视频
Updated: Jan 14, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.5K
晚期慢性病的当代管理:基于证据的综述
Lyle W Baker1, Cene Ovincy1, Levon Souvalian2
1Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
European journal of internal medicine
|October 23, 2025
概括
新的CKD治疗方法,如SGLT2抑制剂和GLP-1激动剂,可以改善心脏结局. 包括再生医学在内的新兴疗法正在将慢性病护理转向精确,基于机制的方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 再生医学是一种再生医学.
背景情况:
- 慢性病 (CKD) 是全球发病率和死亡率的主要原因之一.
- 传统的管理依赖于氨酸 - 血管新生素系统 (RAS) 的抑制和支持性护理.
- 最近的进展提供了有针对性的干预措施,以改变疾病的进展和改善结果.
研究的目的:
- 审查慢性病 (CKD) 的新兴治疗策略.
- 突出影响心血管和结局的新型治疗方法.
- 讨论在病学中向精准医学的转变.
主要方法:
- 对关于新型CKD疗法的当前文献的综述.
- 临床试验数据和现实世界的证据的摘要.
- 分析新兴的再生方法.
主要成果:
- -葡萄糖共运输体2 (SGLT2) 抑制剂和葡萄糖类-1 (GLP-1) 受体激活剂显示出显著的心脏和脏益处,特别是在2型糖尿病 (T2DM) 中.
- 非类固醇矿物质皮质体受体对抗剂 (nsMRAs),如芬,提供保护,降低了高血症的风险.
- 托尔瓦普坦对自身主导多囊性病 (ADPKD) 有效;像干细胞治疗和异种移植这样的再生策略显示出早期的希望.
结论:
- 新兴的疗法正在转变CKD管理,以机制为基础,精确医学.
- SGLT2抑制剂和GLP-1受体激动剂是关键的进展.
- 再生医学在治疗慢性病方面具有未来的潜力.
- 内部医学临床医生在采用这些新疗法方面发挥着至关重要的作用.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
335
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
335
01:18Chronic Kidney Disease IV: Nursing Management
314
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
314
01:20Acute Kidney Injury V: Interprofessional Care
295
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
295
01:25Chronic Kidney Disease I: Introduction
557
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
557
01:22Acute Kidney Injury VI: Nursing Management
381
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
381
01:24Chronic Kidney Disease II: Clinical Manifestations
547
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
547